Inozyme Pharma, Inc.

NASDAQ (USD): Inozyme Pharma, Inc. (INZY)

Last Price

1.51

Today's Change

-0.21 (12.20%)

Day's Change

1.45 - 1.77

Trading Volume

1,527,377

Overview

Market Cap

97 Million

Shares Outstanding

64 Million

Avg Volume

589,057

Avg Price (50 Days)

3.09

Avg Price (200 Days)

4.57

PE Ratio

-0.97

EPS

-1.55

Earnings Announcement

10-Mar-2025

Previous Close

1.72

Open

1.71

Day's Range

1.45 - 1.77

Year Range

1.45 - 7.795

Trading Volume

1,527,694

Price Change Highlight

1 Day Change

-12.21%

5 Day Change

-44.28%

1 Month Change

-50.17%

3 Month Change

-71.88%

6 Month Change

-72.34%

Ytd Change

-47.02%

1 Year Change

-63.53%

3 Year Change

-77.36%

5 Year Change

-91.39%

10 Year Change

-91.39%

Max Change

-91.39%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Inozyme Pharma, Inc., a rare disease biopharmaceutical company, engages in developing therapeutics for treating abnormal mineralization impacting the vasculature, soft tissue, and skeleton diseases. The company's lead product candidate is INZ-701, a soluble, recombinant protein to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies, as well as for the treatment of calciphylaxis. It has a license agreement with Yale University for specified therapeutic and prophylactic products. Inozyme Pharma, Inc. was incorporated in 2015 and is headquartered in Boston, Massachusetts.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment